EUVIMEDEUVIMED entdecken
Open Access

Pathologic complete response and survival in early-stage HER2-positive breast cancer patients treated with or without anthracyclines

Francisco Acevedo, Benjamín Walbaum, Lidia Medina, Maritza Abud, Roger Gejman, Pablo Zoroquiain, Francisco Domínguez, Mauricio Camus, Catalina Vargas, Marisel Navarro, Constanza Pinto, Catalina Muñoz und 2 weitere

ecancermedicalscience · 06.05.2026 · 20

DOI: 10.3332/ecancer.2026.2118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ecancermedicalscience, online erschienen am 06.05.2026. Verfasst von Francisco Acevedo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8320165, Chile. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

HER2-positive breast canceranthracyclinesneoadjuvant chemotherapypathologic complete responsetrastuzumab

Autor:innen und Institutionen

  • Department of Hematology and Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8320165, Chile.
  • "Nuestra Señora de la Esperanza" Cancer Center, UC Christus Health Network, Pontificia Universidad Católica de Chile, Santiago 8320165, Chile.
  • Department of Pathology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8320165, Chile.
  • Department of Surgery, School of Medicine, Pontificia Universidad Católica de Chile, Santiago 8320165, Chile.
  • Dr. Sótero del Rio Hospital and Healthcare Complex, Santiago 8207257, Chile.
  • Department of Biochemistry, School of Biology, Pontificia Universidad Católica de Chile, Santiago 8320165, Chile.

Zitieren

APA

Acevedo, F., Walbaum, B., Medina, L., Abud, M., Gejman, R., Zoroquiain, P., Domínguez, F., Camus, M., Vargas, C., Navarro, M., Pinto, C., Muñoz, C., Manzor, M., & Sánchez, C. (2026). Pathologic complete response and survival in early-stage HER2-positive breast cancer patients treated with or without anthracyclines. ecancermedicalscience, 20. https://doi.org/10.3332/ecancer.2026.2118

Vancouver

Acevedo F, Walbaum B, Medina L, Abud M, Gejman R, Zoroquiain P, et al. Pathologic complete response and survival in early-stage HER2-positive breast cancer patients treated with or without anthracyclines. ecancermedicalscience. 2026;20. doi:10.3332/ecancer.2026.2118

BibTeX
@article{Acevedo2026,
  author = {Acevedo, Francisco and Walbaum, Benjamín and Medina, Lidia and Abud, Maritza and Gejman, Roger and Zoroquiain, Pablo and Domínguez, Francisco and Camus, Mauricio and Vargas, Catalina and Navarro, Marisel and Pinto, Constanza and Muñoz, Catalina and Manzor, Manuel and Sánchez, César},
  title = {Pathologic complete response and survival in early-stage HER2-positive breast cancer patients treated with or without anthracyclines},
  journal = {ecancermedicalscience},
  year = {2026},
  volume = {20},
  doi = {10.3332/ecancer.2026.2118}
}
Kostenlos starten →